ReviewOncology reviews2026

Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology.

Emmanuel Ifeanyi ObeaguPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.